The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease

被引:3997
作者
Lamb, Justin
Crawford, Emily D.
Peck, David
Modell, Joshua W.
Blat, Irene C.
Wrobel, Matthew J.
Lerner, Jim
Brunet, Jean-Philippe
Subramanian, Aravind
Ross, Kenneth N.
Reich, Michael
Hieronymus, Haley
Wei, Guo
Armstrong, Scott A.
Haggarty, Stephen J.
Clemons, Paul A.
Wei, Ru
Carr, Steven A.
Lander, Eric S.
Golub, Todd R. [1 ]
机构
[1] MIT, Broad Inst, Cambridge, MA 02142 USA
[2] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA
[3] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
[4] Childrens Hosp, Dept Med, Boston, MA 02115 USA
[5] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02144 USA
[6] Harvard Univ, Sch Med, Boston, MA 02115 USA
[7] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
[8] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA
关键词
D O I
10.1126/science.1132939
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a reference collection of gene-expression profiles from cultured human cells treated with bioactive small molecules, together with pattern-matching software to mine these data. We demonstrate that this "Connectivity Map'' resource can be used to find connections among small molecules sharing a mechanism of action, chemicals and physiological processes, and diseases and drugs. These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.
引用
收藏
页码:1929 / 1935
页数:7
相关论文
共 41 条
[31]
RELATION OF CELLULAR-DRUG RESISTANCE TO LONG-TERM CLINICAL OUTCOME IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
PIETERS, R ;
HUISMANS, DR ;
LOONEN, AH ;
HAHLEN, K ;
VANDERDOESVANDENBERG, A ;
VANWERING, ER ;
VEERMAN, AJP .
LANCET, 1991, 338 (8764) :399-403
[32]
Prediction of central nervous system embryonal tumour outcome based on gene expression [J].
Pomeroy, SL ;
Tamayo, P ;
Gaasenbeek, M ;
Sturla, LM ;
Angelo, M ;
McLaughlin, ME ;
Kim, JYH ;
Goumnerova, LC ;
Black, PM ;
Lau, C ;
Allen, JC ;
Zagzag, D ;
Olson, JM ;
Curran, T ;
Wetmore, C ;
Biegel, JA ;
Poggio, T ;
Mukherjee, S ;
Rifkin, R ;
Califano, A ;
Stolovitzky, G ;
Louis, DN ;
Mesirov, JP ;
Lander, ES ;
Golub, TR .
NATURE, 2002, 415 (6870) :436-442
[33]
Microarray analysis in Alzheimer's disease and normal aging [J].
Ricciarelli, R ;
d'Abramo, C ;
Massone, S ;
Marinari, UM ;
Pronzato, MA ;
Tabaton, M .
IUBMB LIFE, 2004, 56 (06) :349-354
[34]
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles [J].
Subramanian, A ;
Tamayo, P ;
Mootha, VK ;
Mukherjee, S ;
Ebert, BL ;
Gillette, MA ;
Paulovich, A ;
Pomeroy, SL ;
Golub, TR ;
Lander, ES ;
Mesirov, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (43) :15545-15550
[35]
Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia [J].
Tissing, WJE ;
Meijerink, JPP ;
den Boer, ML ;
Pieters, R .
LEUKEMIA, 2003, 17 (01) :17-25
[36]
Gene expression profiling predicts clinical outcome of breast cancer [J].
van't Veer, LJ ;
Dai, HY ;
van de Vijver, MJ ;
He, YDD ;
Hart, AAM ;
Mao, M ;
Peterse, HL ;
van der Kooy, K ;
Marton, MJ ;
Witteveen, AT ;
Schreiber, GJ ;
Kerkhoven, RM ;
Roberts, C ;
Linsley, PS ;
Bernards, R ;
Friend, SH .
NATURE, 2002, 415 (6871) :530-536
[37]
VANDERHOEK JY, 1979, MOL PHARMACOL, V16, P171
[38]
WAKELING AE, 1991, CANCER RES, V51, P3867
[39]
Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles [J].
Waring, JF ;
Jolly, RA ;
Ciurlionis, R ;
Lum, PY ;
Praestgaard, JT ;
Morfitt, DC ;
Buratto, B ;
Roberts, C ;
Schadt, E ;
Ulrich, RG .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2001, 175 (01) :28-42
[40]
WEI G, IN PRESS CANC CELL